Skip to main content

Nonprofit · EIN 36-3320440

FAMILIES OF SMA

Also known as CURE SMA

Tax-exempt · ELK GROVE VLG, IL 60007

Financials

$14.8M$15.6M2023$15.2M$14M2024
Revenue Expenses · by fiscal year end
Financials of FAMILIES OF SMA by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$15,213,970$14,019,399$1,194,571$10,645,251$3,222,762$7,422,489
June 30, 2024990$14,785,235$15,621,865-$836,630$10,703,968$4,582,639$6,121,329
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$7,673,243
Program service revenue
$6,912,298
Investment income
$209,381
Net gain from sales of assets
$56,557
Net income from fundraising events
$104,641
Other revenue
$419,048

Expenses

Grants and similar amounts paid
$2,564,862
Compensation of officers, directors and key employees
$1,168,801
Other salaries and wages
$3,747,629
Salaries, compensation and benefits (total)
$5,683,143
Professional fundraising fees
$0
Legal fees
$4,425
Accounting fees
$36,050
Occupancy
$123,018
Travel
$204,728
Depreciation
$135,755
Program services (functional)
$10,840,169
Management and general (functional)
$1,300,650
Fundraising (functional)
$1,878,580

Balance sheet and other

Total assets, start of year
$10,703,968
Total assets, end of year
$10,645,251
Total liabilities, end of year
$3,222,762
Net assets, end of year
$7,422,489
Land, buildings and equipment
$59,085
Publicly traded securities
$2,391,493
Net assets without donor restrictions
$2,609,833
Net assets with donor restrictions
$4,812,656
Gross receipts
$16,238,049
Employees
53
Volunteers
6,800
Year formed
1984
State of legal domicile
IL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
KENNETH HOBBYPRESIDENT
Officer
70$329,195$19,611
JAMIE GIBSONCHIEF DEVELOPMENT OFFICER
Key employee
60$266,038$28,541
MARLINE PAGANCHIEF OPERATING OFFICER
Key employee
60$208,905$30,552
MARY SCHROTHCHIEF MEDICAL OFFICER (THROUGH 3/31/25)
Key employee
60$218,342$10,202
COLLEEN MCCARTHY O'TOOLESR VICE PRESIDENT, COMMUNI
Highest-paid employee
60$175,435$27,061
MAYNARD FRIESZVICE PRESIDENT, POLICY
Highest-paid employee
50$149,595$13,548
MARY CURRYVICE PRESIDENT, CLINICAL RESEARCH & CARE
Highest-paid employee
50$138,474$20,241
JACKIE GLASCOCKVICE PRESIDENT OF RESEARCH
Highest-paid employee
50$146,346$7,311
JESSE AYNESVICE PRESIDENT OF DEVELOPMENT
Highest-paid employee
50$135,299$9,819
ROBERT GRAHAMDIRECTOR
Trustee or director
2$0$0
PETER STATILEDIRECTOR
Trustee or director
2$0$0
MARK MOOREDIRECTOR
Trustee or director
2$0$0
MARC GINSKYDIRECTOR
Trustee or director
2$0$0
KAREN MCROY-NEGRINDIRECTOR
Trustee or director
2$0$0
BAKRI ELSHEIKHDIRECTOR
Trustee or director
2$0$0
21 more people on this return
NameTitleHours / weekCompensation
JOE WISEMANDIRECTOR
Trustee or director
2$0
ROB LOCKWOODDIRECTOR
Trustee or director
2$0
KELLY JANKOWSKIDIRECTOR
Trustee or director
2$0
AMY MEDINADIRECTOR
Trustee or director
2$0
GILLIAN MULLINSDIRECTOR (THROUGH 12/31/24)
Trustee or director
2$0
EDMUND LEEDIRECTOR (THROUGH 12/31/24)
Trustee or director
2$0
DIANA CASTRODIRECTOR
Trustee or director
2$0
BRIAN SNYDERDIRECTOR
Trustee or director
2$0
BRIANNA GROSSDIRECTOR
Trustee or director
2$0
JACLYN GREENWOODDIRECTOR
Trustee or director
2$0
COREY BRAASTADDIRECTOR
Trustee or director
2$0
ALLYSON HENKELDIRECTOR
Trustee or director
2$0
COLLIN POLLOCKDIRECTOR (START 4/26/25)
Trustee or director
2$0
RACHEL BROWNDIRECTOR (START 4/26/25)
Trustee or director
2$0
TYLER DUKESDIRECTOR (START 4/26/25)
Trustee or director
2$0
KALEEN ROBINSONDIRECTOR
Trustee or director
2$0
SPENCER PERLMANDIRECTOR
Trustee or director
2$0
NICK FARRELLBOARD CHAIR
Trustee or director, Officer
5$0
BRADLEY A NUNEMAKERTREASURER & VICE CHAIR
Trustee or director, Officer
5$0
SHANNON ZERZANDIRECTOR
Trustee or director
5$0
JOHN WEBERDIRECTOR (START 10/1/2024)
Trustee or director
2$0
990 for the year ended June 30, 2024: 32 people
NameTitleHours / weekCompensationOther / benefits
KENNETH HOBBYPRESIDENT
Officer
70$338,969$19,102
MARY SCHROTHCHIEF MEDICAL OFFICER
Key employee
60$280,222$19,442
MARLINE PAGANCHIEF OPERATING OFFICER
Key employee
60$223,535$28,697
COLLEEN MCCARTHY O'TOOLESR VICE PRESIDENT, COMMUNI
Highest-paid employee
60$176,138$26,598
MAYNARD FRIESZVICE PRESIDENT, POLICY
Highest-paid employee
50$145,434$17,927
AMY THOMASSONVICE PRESIDENT, MARKETING & COMMUNICATION (THROUGH
Highest-paid employee
50$147,429$4,173
JACKIE GLASCOCKVICE PRESIDENT OF RESEARCH
Highest-paid employee
40$143,876$6,919
JAMIE GIBSONCHIEF DEVELOPMENT OFFICER
Highest-paid employee
40$142,692$6,953
ALLYSON HENKELDIRECTOR
Trustee or director
2$0$0
AMY MEDINADIRECTOR
Trustee or director
2$0$0
BAKRI ELSHEIKHDIRECTOR
Trustee or director
2$0$0
BRAD NUNEMAKERTREASURER & VICE CHAIR
Trustee or director, Officer
5$0$0
BRIAN SNYDERDIRECTOR
Trustee or director
2$0$0
BRIANNA GROSSDIRECTOR (START 1/1/24)
Trustee or director
2$0$0
COREY BRAASTADDIRECTOR
Trustee or director
2$0$0
DIANA CASTRODIRECTOR
Trustee or director
2$0$0
EDMUND LEEDIRECTOR
Trustee or director
2$0$0
GILLIAN MULLINSDIRECTOR
Trustee or director
2$0$0
JACLYN GREENWOODDIRECTOR
Trustee or director
2$0$0
JOE WISEMANDIRECTOR (START 4/20/24)
Trustee or director
2$0$0
KALEEN ROBINSONDIRECTOR
Trustee or director
2$0$0
KAREN MCROY-NEGRINDIRECTOR (START 1/1/24)
Trustee or director
2$0$0
KELLY JANKOWSKIDIRECTOR
Trustee or director
2$0$0
MARC GINSKYDIRECTOR (START 4/20/24)
Trustee or director
2$0$0
MARK MOOREDIRECTOR (START 4/20/24)
Trustee or director
2$0$0
NICK FARRELLBOARD CHAIR
Trustee or director, Officer
5$0$0
PETER STATILEDIRECTOR
Trustee or director
2$0$0
ROB LOCKWOODDIRECTOR
Trustee or director
2$0$0
ROBERT GRAHAMDIRECTOR
Trustee or director
2$0$0
SHANNON ZERZANDIRECTOR
Trustee or director
2$0$0
SPENCER PERLMANDIRECTOR
Trustee or director
2$0$0
TOM MURRAYDIRECTOR (THROUGH 12/31/23)
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
925 BUSSE RD, ELK GROVE VLG, IL 60007-2400
Principal officer (990 for 2024)
KENNETH HOBBY, 50 E COMMERCE DR 90, SCHAUMBURG, IL 60173
Signed the 990
KENNETH HOBBY, PRESIDENT
Phone
(847) 709-6318
Return prepared by
WARADY & DAVIS LLP

Mission

OUR MISSION IS TO DRIVE RESEARCH FOR TREATMENTS AND A CURE FOR SMA, AND TO SUPPORT AND EMPOWER EVERYONE IMPACTED BY SMA TODAY.

990 for the year ended June 30, 2025

Program accomplishments

  • INDIVIDUALS WITH SMA NEED SPECIALIZED CARE AND EQUIPMENT, WHICH CAN PUT ENORMOUS LOGISTICAL AND FINANCIAL PRESSURE ON FAMILIES. CURE SMA IS COMMITTED TO MAKING SURE THAT FAMILIES HAVE THE BEST, MOST ACCURATE INFORMATION ABOUT SMA AND WHAT IT MEANS FOR THEM, AND TO MAKING SURE THAT THEY UNDERSTAND ALL THE OPTIONS AND RESOURCES AVAILABLE TO THEM FROM DAY-TO-DAY CARE TO THE CHANGING LANDSCAPE OF RESEARCH BREAKTHROUGHS AND TREATMENTS. THIS INCLUDES OUR CARE SERIES BOOKLETS, WHICH ARE SENT OUT AS PART OF INFORMATIONAL PACKETS AVAILABLE AT NO COST TO ANYONE WHO REQUESTS ONE. DEVELOPED BY MEDICAL EXPERTS AND REVIEWED BY FAMILIES, THESE BOOKLETS COVER TOPICS SUCH AS BREATHING, NUTRITION, PALLIATIVE CARE, GENETICS, MUSCULOSKELETAL ISSUES, AND MORE. IN ADDITION, OUR EQUIPMENT POOL GIVES FAMILIES ACCESS TO SPECIALIZED ITEMS LIKE CAR BEDS, STROLLERS AND BATHING SYSTEMS AT NO COST. EVERY NEWLY-DIAGNOSED FAMILY RECEIVES A CARE PACKAGE FROM CURE SMA, FULL OF TOYS APPROPRIATE TO THE CHILD'S TYPE OF THE DISEASE, IMPARTIAL INFORMATION FOR PARENTS, AND USEFUL ITEMS SUGGESTED BY OTHER SMA PARENTS BASED ON THEIR OWN EXPERIENCES. EVERY NEW ADULT TO THE COMMUNITY RECEIVES A PACKAGES OF SPECIAL INDEPENDENCE RELATED ITEMS.CURE SMA ALSO EDUCATES THE PUBLIC ABOUT SMA, TO STRENGTHEN THE SUPPORT AVAILABLE TO FAMILIES. THIS INCLUDES DIRECTIONS, A BIANNUAL FAMILY SUPPORT NEWSLETTER, AND COMPASS, A QUARTERLY UPDATE ON RESEARCH DEVELOPMENTS
    Expenses $4,835,026 · grants $196,619 · revenue $245,468
  • CURE SMA FOCUSES ON THREE DIFFERENT YET EQUALLY CRITICAL AND INTERDEPENDENT RESEARCH AREAS: BASIC RESEARCH, TO UNDERSTAND THE CAUSE AND BIOLOGY OF SMA; DRUG DISCOVERY, TO CONVERT BASIC RESEARCH IDEAS INTO PRACTICAL NEW DRUG CANDIDATES; AND CLINICAL & REGULATORY RESEARCH, TO PROVIDE THE INFRASTRUCTURE TO TEST THE DRUG CANDIDATES. DURING THIS PERIOD CURE SMA FUNDED SIX NEW AND SIX ONGOING BASIC RESEARCH GRANTS. WE ALSO FUNDED AND EXECUTED MULTIPLE CLINICAL AND REGULATORY FOCUSED PROJECTS, TO INCREASE SMA CLINICAL TRIAL SITE CAPACITY AND READINESS, TO PROVIDE REGULATORY AUTHORITIES WITH DATA ON THE SMA POPULATION AND THEIR REPORTED UNMET NEEDS, AND TO COLLECT DATA TO UNDERSTAND THE PATIENT EXPERIENCE WITH SMA. CURRENTLY, THERE ARE THREE APPROVED DRUGS FOR SMA, WITH ANOTHER SEVERAL DOZEN DRUG PROGRAMS IN DEVELOPMENT, INCLUDING FIVE IN CLINICAL TRIALS. CURRENTLY, TWO INVESTIGATIONAL DRUGS ARE AWAITING FDA APPROVAL.CURE SMA HAVE THREE PRIMARY DATABASES FOR DATA COLLECTION: A PATIENT-REPORTED DATABASE WITH DATA FROM OVER 11,000 IMPACTED INDIVIDUALS WORLDWIDE THAT ALSO INCORPORATES LONGITUDINAL DATA FROM OUR ANNUAL COMMUNITY UPDATE SURVEY; THE SMA CLINICAL DATA REGISTRY (CDR) THAT CONTAINS ELECTRONIC MEDICAL RECORD (EMR) SOURCED DATA FROM U.S. BASED SMA CARE CENTER NETWORK SITES; AND THE NEWBORN SCREENING REGISTRY WITH DATA FROM PARENTS OF BABIES WITH SMA THAT WERE IDENTIFIED THROUGH STATEWIDE SMA NEWBORN SCREENING. THE ABOVE DATA SOURCES ARE COMBINED AND ANALYZED ANNUALLY TO IDENTIFY TRENDS IN DEMOGRAPHICS, DIAGNOSIS, SMA TREATMENTS, UNMET NEEDS, PATIENT CARE AND OUTCOMES. THE MOST RECENT ANALYZES WERE PUBLISHED IN THE STATE OF SMA 2024 REPORT AVAILABLE ON OUR WEBSITE. DATA COLLECTED IS ALSO SHARED IN PEER-REVIEWED LITERATURE. CURE SMA PUBLISHED "SMA COMMUNITY PRIORITIES FOR FUTURE DRUG THERAPIES: CROSS-SECTIONAL SURVEY FINDING REPRESENTING 410 ADULTS WITH SMA" IN NEUROLOGY AND THERAPY IN JUNE 2025. IN ADDITION, CURE SMA SUPPORTS THE SMA INDUSTRY COLLABORATION. ESTABLISHED IN 2016, THE COLLABORATION IS A MULTI-FACETED PARTNERSHIP THAT BRINGS TOGETHER PHARMACEUTICAL COMPANIES, CURE SMA, AND OTHER NONPROFIT ORGANIZATIONS TO SHARE INFORMATION, IDEAS, AND DATA. THE SMA INDUSTRY COLLABORATION WORKS TOGETHER TO ADDRESS SCIENTIFIC, CLINICAL, AND REGULATORY TOPICS THAT ARE CRITICAL TO ADVANCING DRUG DEVELOPMENT IN SMA AND WILL BENEFIT THE BROADER SMA COMMUNITY. CURE SMA CO-CREATED A NEW HEALTHCARE PROVIDER ENDURING CONTINUING MEDICAL EDUCATION PROGRAM IN ADDITION TO THE IN-PERSON CURE SMA CLINICAL CARE SESSION OFFERED IN JUNE 2025. RESOURCES WERE ALSO DEVOTED TO MAINTAINING WEBSITE LISTINGS OF SMA NEWBORN SCREENING REFERRAL CENTERS AND TREATMENT CENTERS THAT PROVIDE FDA-APPROVED SMA TREATMENTS.
    Expenses $5,416,203 · grants $2,368,243 · revenue $1,650,318
  • WE HOSTED THE 2025 ANNUAL SMA CONFERENCE IN ANAHEIM, CA WITH OVER 2,739 REGISTERED ATTENDEES. OUR ANNUAL CONFERENCE IS AN INVALUABLE RESOURCE FOR THE ENTIRE SMA COMMUNITY. THE CONFERENCE IS THE LARGEST IN THE WORLD FOCUSED SPECIFICALLY ON SMA. THE RESEARCHER AND CLINICAL CARE CONFERENCE ATTRACTED THE TOP SCIENTISTS AND COMPANIES IN THE FIELD. THE COMMUNITY CONFERENCE INCLUDES A VARIETY OF WORKSHOPS, KEYNOTE SESSIONS WITH LEADING EXPERTS, AND MORE-PLUS GREAT EVENTS SUCH AS OUR TEEN AND ADULTS WITH SMA SOCIALS, THE FAMILY FRIENDLY RESEARCHER POSTER SESSION AND OUR MEET & GREET, WITH A FAMILY FUN FEST. THE RESEARCHER AND CLINICAL CARE CONFERENCE CREATES OPEN COMMUNICATION OF EARLY, UNPUBLISHED SCIENTIFIC DATA, ACCELERATING THE PACE OF RESEARCH. THE MEETING ALSO FURTHERS RESEARCH BY BUILDING PRODUCTIVE COLLABORATIONSINCLUDING CROSS-DISCIPLINARY DIALOGUE, PARTNERSHIPS, INTEGRATION OF NEW RESEARCHERS AND DRUG COMPANIES, AND EDUCATIONAL OPPORTUNITIES FOR JUNIOR RESEARCHERS. COMMUNITY ATTENDEES HAVE DIRECT ACCESS TO THE LATEST INFORMATION ABOUT RESEARCH, AND RESEARCHERS HAVE AN OPPORTUNITY TO BUILD PERSONAL CONNECTIONS WITH THE PATIENTS WHO WILL BENEFIT FROM THEIR WORK.
    Expenses $588,940 · revenue $5,330,919

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
36-3320440
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1985
Accounting year ends
June
Files
Form 990 or 990-EZ
Assets (IRS master file)
$10,645,251
Income (IRS master file)
$16,238,049

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$15,213,970$14,019,399$10,645,251XML
990June 2024$14,785,235$15,621,865$10,703,968XML
990June 2023$13,668,775$14,203,228$12,713,304IRS
990June 2022–––IRS
990June 2021–––IRS
990June 2019–––IRS
990June 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 36-3320440).

Questions about FAMILIES OF SMA

What is the EIN of FAMILIES OF SMA?
The employer identification number (EIN) of FAMILIES OF SMA is 36-3320440.
Is FAMILIES OF SMA tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1985.
Are donations to FAMILIES OF SMA tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does FAMILIES OF SMA file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of FAMILIES OF SMA due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did FAMILIES OF SMA last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of FAMILIES OF SMA?
The 990 for the year ended June 30, 2025 names KENNETH HOBBY.
Who are the officers and directors of FAMILIES OF SMA?
The 990 for the year ended June 30, 2025 lists 36 people; 9 received compensation from the organization, the highest $329,195 (KENNETH HOBBY, PRESIDENT).
How much revenue does FAMILIES OF SMA have?
On its 990 for the year ended June 30, 2025 it reported revenue of $15,213,970, expenses of $14,019,399 and total assets of $10,645,251 at year end.

Other nonprofits in ELK GROVE VLG

All nonprofits in ELK GROVE VLG · Illinois · Voluntary health associations and medical disciplines